Management strategies for gastro‐oesophageal reflux disease
Author:
- 1 December 1997
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 11 (s2) , 99-105
Abstract
SUMMARY: New trials allow management strategies to be proposed with greater confidence than in the past for the entire spectrum of gastro‐oesophageal reflux disease. Symptom evaluation is of key importance, as it is the most cost‐effective and sensitive method for diagnosis of gastro‐oesophageal reflux disease, and for tailoring of long‐term therapy to individual patients. Endoscopy is an important adjunct to symptom assessment, but needs to be used sparingly and critically to be cost‐effective. Empirical therapy, with evaluation of symptom response, is a central management strategy that can minimize overall costs. In cases of diagnostic uncertainty, a 1–2‐week diagnostic/therapeutic test with high dose acid pump inhibitor is an emerging attractive alternative to oesophageal pH monitoring. Choice of therapy, and its subsequent adjustment to individual patients, should be made in the light of a now well‐defined hierarchy of efficacy, which is essentially the same for endoscopy‐negative and oesophagitis patients. Management strategies must acknowledge that gastro‐oesophageal reflux disease is a chronic disorder in the majority of oesophagitis and endoscopy‐negative patients. Management steps should identify the most cost‐effective long‐term treatment that gives adequate relief of symptoms and so corrects any symptom‐related impairment of quality of life. The strategies that are recommended are largely based on clinical trial outcomes. There is a need for formal clinical trials of management strategies as distinct from evaluations of specific therapies.Keywords
This publication has 17 references indexed in Scilit:
- Omeprazole or Ranitidine Plus Metoclopramide for Patients with Severe Erosive OesophagitisPharmacoEconomics, 1995
- Omeprazole as a diagnostic tool in gastro-esophageal reflux disease: , EC. Klinkenberg-Knol, EH. Jansen, HARE. Tuynman, HPM. Festen, M. Schrijver, SGM. Meuwissen. Depts. of Gastroenterol, Free Univ Hosp Amsterdam, Lange Land Hosp Zoetermeer, Med Center Alkmaar, Bosch Med Centre, Den Bosch and Bronovo Hosp Den Haag, The NetherlandsGastroenterology, 1995
- Effect of cisapride on relapse of esophagitisDigestive Diseases and Sciences, 1993
- Cimetidine improves GERD symptoms in patients selected by a validated GERD questionnaireAlimentary Pharmacology & Therapeutics, 1993
- Study of 47 consecutive patients with peptic esophageal stricture compared with 3880 cases of reflux esophagitisDigestive Diseases and Sciences, 1992
- Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease.Gut, 1992
- Epidemiology and Natural History of Gastro-Oesophageal Reflux DiseaseDigestion, 1992
- Healing and prevention of relapse of reflux oesophagitis by cisapride.Gut, 1991
- Symptoms in gastro-oesophageal reflux diseaseThe Lancet, 1990
- Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trialBMJ, 1988